Position effect on nausea and vomiting in cancer patients

Effect of semi-sitting position on nausea and vomiting during chemotherapy in patients tohid Medical Center of sanandj-1389-90

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201111268208N1

Enrollment

Registered

2013-01-15

Start date

2010-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer. Malignant neoplasms

Interventions

Intervention 1: Intervention group were semi position When chemotherapy was doing. Intervention 2: Control group, was supine routine At the time of chemotherapy.

Behavior

Treatment - Drugs

Intervention group were semi position When chemotherapy was doing.

Control group, was supine routine At the time of chemotherapy

Eligibility

Sex/Gender

All

Age

15 Years to 80 Years

Inclusion criteria

Inclusion criteria: Criteria, the risk of cancer, but chemotherapy is used, aged between 80-15 years of healthy middle ear system. Stomach, the patient is healthy. The ion is normal. Exclusion criteria, the diagnosis of cancers of the stomach and the brain; require other treatments such as surgery and radiotherapy, age less than 15 or more than 80 years, pregnancy is a history of middle ear disease, vertigo and motion sickness, there is a history of stomach surgery, disorders ion is particularly hypokalemia and Hypocalcemia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Nausea frequency. Timepoint: Sat 24 hours and once every three. Method of measurement: Statements patient and chklist.;Nausea Duration. Timepoint: Within 24 hours and once every three hours and were recorded separately. Method of measurement: Observed and the time number of seconds.;Nausea Severity. Timepoint: Every three hours for 24 hours. Method of measurement: Visual analog scale (VAS).;Severity vomiting. Timepoint: Sat 24 hours and once every three. Method of measurement: Tool (scale Oncology) in mild, moderate and severe.;Vomitng frequency. Timepoint: Every three hours for 24 hours. Method of measurement: Statements patient and chklist.	—

Measure

Time frame

Nausea frequency. Timepoint: Sat 24 hours and once every three. Method of measurement: Statements patient and chklist.;Nausea Duration. Timepoint: Within 24 hours and once every three hours and were recorded separately. Method of measurement: Observed and the time number of seconds.;Nausea Severity. Timepoint: Every three hours for 24 hours. Method of measurement: Visual analog scale (VAS).;Severity vomiting. Timepoint: Sat 24 hours and once every three. Method of measurement: Tool (scale Oncology) in mild, moderate and severe.;Vomitng frequency. Timepoint: Every three hours for 24 hours. Method of measurement: Statements patient and chklist.

—

Secondary

Measure	Time frame
Vital signs. Timepoint: Start and every six hours. Method of measurement: Routine procedure.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad Fathi

Kurdistan University of Medical Sciences

Mohamad.Fathi@muk.ac.ir+98 87 1662 7636

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026